why does glp 1 increase heart rate GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential Role of Glucagon-like Peptide-1 Receptor

While rodent studies showed thyroid tumors, no clear causal relationship exists in humans

Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, et al

In 2025, Novo Nordisk submitted Orforglipron for regulatory review by the FDA, but it is not yet approved

Need access to multiple GLP-1 medication options including brand-name drugs

A clinical study involving 78 non-diabetic overweight/obese patients found that BN may be a more effective treatment option for overweight/obese Chinese than metformin (43)

Kruegel's lab actually did once apply for a schedule 1 license to study a different banned substance, but it ended up abandoning the project because obtaining the license was too onerous